Matches in SemOpenAlex for { <https://semopenalex.org/work/W2915696410> ?p ?o ?g. }
- W2915696410 abstract "Clarithromycin-containing bismuth quadruple therapy has been recommended as the first-line therapy for H pylori infection in China. However, its expensive cost and high antibiotic-related adverse reactions are always haunting us. To find a safer, more cost-effective, and high eradicative strategy for Helicobacter treatment, we investigated the efficacy of 14-day bismuth quadruple therapy and different doses of clarithromycin in the first-line treatment.A total of 210 patients with H pylori infection were recruited and randomly assigned to half-dose clarithromycin group (esomeprazole 20 mg bid, amoxicillin 1 g bid, clarithromycin 250 mg bid, and bismuth potassium citrate 0.6 g bid) for 14 days or standard-dose clarithromycin group (esomeprazole 20 mg bid, amoxicillin 1 g bid, clarithromycin 500 mg bid, and bismuth potassium citrate 0.6 g bid) for 14 days. A 13 C-urea breath test (13 C-UBT) was performed at least 4 weeks after treatment. The eradication rate of H pylori, the incidence of side effects, and the cost-effectiveness of regimens were evaluated in this study.The eradication frequencies were 86.67% for both groups in the intention-to-treat analysis, while the per-protocol eradication rates were 91% vs. 91.92% (p=0.817). The incidence of adverse events was higher in standard dose group (54.21% vs. 34.29%; p=0.004), especially bitter taste symptom. There was a higher level of costs per person associated with the standard-dose group as compared with half-dose group (¥804.3 vs ¥654.36). The cost-effectiveness ratio of the half dose was less than that of the standard dose (7.55 vs 9.16 CNY per percent).A 14-day half-dose clarithromycin-containing bismuth quadruple regimen is as effective as the standard bismuth quadruple therapy at eradicating H pylori, which is better tolerated and more economical. (ChiCTR-ROC-15007406)." @default.
- W2915696410 created "2019-03-02" @default.
- W2915696410 creator A5002786739 @default.
- W2915696410 creator A5006094979 @default.
- W2915696410 creator A5030816903 @default.
- W2915696410 creator A5054700121 @default.
- W2915696410 creator A5069712136 @default.
- W2915696410 date "2019-02-19" @default.
- W2915696410 modified "2023-10-05" @default.
- W2915696410 title "Half‐dose clarithromycin‐containing bismuth quadruple therapy is effective and economical in treating <i>Helicobacter</i> pylori infection: A single‐center, open‐label, randomized trial" @default.
- W2915696410 cites W1481539727 @default.
- W2915696410 cites W1503002210 @default.
- W2915696410 cites W1809766612 @default.
- W2915696410 cites W1826619807 @default.
- W2915696410 cites W1928201404 @default.
- W2915696410 cites W1965768528 @default.
- W2915696410 cites W1972686135 @default.
- W2915696410 cites W2017178544 @default.
- W2915696410 cites W2026848396 @default.
- W2915696410 cites W2039745983 @default.
- W2915696410 cites W2046549547 @default.
- W2915696410 cites W2048754709 @default.
- W2915696410 cites W2055374239 @default.
- W2915696410 cites W2061938579 @default.
- W2915696410 cites W2085017604 @default.
- W2915696410 cites W2089634709 @default.
- W2915696410 cites W2105622804 @default.
- W2915696410 cites W2110507552 @default.
- W2915696410 cites W2121695082 @default.
- W2915696410 cites W2123848597 @default.
- W2915696410 cites W2136608539 @default.
- W2915696410 cites W2149520160 @default.
- W2915696410 cites W2158362878 @default.
- W2915696410 cites W2162164701 @default.
- W2915696410 cites W2169674958 @default.
- W2915696410 cites W2183787411 @default.
- W2915696410 cites W2263960908 @default.
- W2915696410 cites W2336356383 @default.
- W2915696410 cites W2527848138 @default.
- W2915696410 cites W2531963478 @default.
- W2915696410 cites W2570545936 @default.
- W2915696410 cites W2570938003 @default.
- W2915696410 cites W2588772815 @default.
- W2915696410 cites W2767732784 @default.
- W2915696410 cites W2793923874 @default.
- W2915696410 cites W86677114 @default.
- W2915696410 doi "https://doi.org/10.1111/hel.12566" @default.
- W2915696410 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30780194" @default.
- W2915696410 hasPublicationYear "2019" @default.
- W2915696410 type Work @default.
- W2915696410 sameAs 2915696410 @default.
- W2915696410 citedByCount "11" @default.
- W2915696410 countsByYear W29156964102019 @default.
- W2915696410 countsByYear W29156964102020 @default.
- W2915696410 countsByYear W29156964102021 @default.
- W2915696410 countsByYear W29156964102022 @default.
- W2915696410 countsByYear W29156964102023 @default.
- W2915696410 crossrefType "journal-article" @default.
- W2915696410 hasAuthorship W2915696410A5002786739 @default.
- W2915696410 hasAuthorship W2915696410A5006094979 @default.
- W2915696410 hasAuthorship W2915696410A5030816903 @default.
- W2915696410 hasAuthorship W2915696410A5054700121 @default.
- W2915696410 hasAuthorship W2915696410A5069712136 @default.
- W2915696410 hasConcept C120665830 @default.
- W2915696410 hasConcept C121332964 @default.
- W2915696410 hasConcept C126322002 @default.
- W2915696410 hasConcept C168563851 @default.
- W2915696410 hasConcept C185592680 @default.
- W2915696410 hasConcept C197934379 @default.
- W2915696410 hasConcept C2776409635 @default.
- W2915696410 hasConcept C2776962512 @default.
- W2915696410 hasConcept C2778204628 @default.
- W2915696410 hasConcept C2779708577 @default.
- W2915696410 hasConcept C501593827 @default.
- W2915696410 hasConcept C55493867 @default.
- W2915696410 hasConcept C61511704 @default.
- W2915696410 hasConcept C71924100 @default.
- W2915696410 hasConcept C90924648 @default.
- W2915696410 hasConceptScore W2915696410C120665830 @default.
- W2915696410 hasConceptScore W2915696410C121332964 @default.
- W2915696410 hasConceptScore W2915696410C126322002 @default.
- W2915696410 hasConceptScore W2915696410C168563851 @default.
- W2915696410 hasConceptScore W2915696410C185592680 @default.
- W2915696410 hasConceptScore W2915696410C197934379 @default.
- W2915696410 hasConceptScore W2915696410C2776409635 @default.
- W2915696410 hasConceptScore W2915696410C2776962512 @default.
- W2915696410 hasConceptScore W2915696410C2778204628 @default.
- W2915696410 hasConceptScore W2915696410C2779708577 @default.
- W2915696410 hasConceptScore W2915696410C501593827 @default.
- W2915696410 hasConceptScore W2915696410C55493867 @default.
- W2915696410 hasConceptScore W2915696410C61511704 @default.
- W2915696410 hasConceptScore W2915696410C71924100 @default.
- W2915696410 hasConceptScore W2915696410C90924648 @default.
- W2915696410 hasFunder F4320323165 @default.
- W2915696410 hasIssue "2" @default.
- W2915696410 hasLocation W29156964101 @default.
- W2915696410 hasLocation W29156964102 @default.
- W2915696410 hasOpenAccess W2915696410 @default.
- W2915696410 hasPrimaryLocation W29156964101 @default.
- W2915696410 hasRelatedWork W2050498853 @default.